Zurich, Switzerland

Thomas U Hofer

USPTO Granted Patents = 28 

 

 

Average Co-Inventor Count = 6.5

ph-index = 11

Forward Citations = 416(Granted Patents)


Location History:

  • Zürich, CH (2015)
  • Zuerich, CH (2019)
  • Zurich, CH (2014 - 2023)
  • Schlieren, CH (2021 - 2024)

Company Filing History:


Years Active: 2014-2025

where 'Filed Patents' based on already Granted Patents

28 patents (USPTO):

Title: Thomas U Hofer: Pioneering Innovations in Antibody Therapeutics

Introduction

Thomas U Hofer, located in Zurich, Switzerland, is a prominent inventor with an impressive portfolio of 27 patents. His work primarily focuses on the development of innovative antibody therapies, which have the potential to significantly advance treatment options in the medical field.

Latest Patents

Among his latest patents, one notable invention is centered around "Antibodies binding to STEAP-1." This invention relates to antibodies that specifically bind to the STEAP-1 protein, including bispecific antigen-binding molecules aimed at activating T cells. The patent also covers the polynucleotides that encode such antibodies, and the vectors and host cells that comprise these polynucleotides. Furthermore, it details methods for producing these antibodies and their applications in treating various diseases.

Another significant innovation is the "Agonistic CD28 antigen binding molecules targeting Her2." This invention details Her2-targeted bispecific agonistic CD28 antigen binding molecules that exhibit monovalent binding to CD28. It includes methods for their production, as well as pharmaceutical compositions containing these antibodies and their applications.

Career Highlights

Throughout his career, Thomas U Hofer has made substantial contributions to the field of biotechnology while working with leading organizations like Roche Glycart AG and Hoffmann-La Roche Inc. His work has not only focused on innovative research but has also led to significant patent filings that demonstrate his expertise and commitment to advancing scientific knowledge.

Collaborations

In his journey as an inventor, Thomas U Hofer has collaborated with esteemed colleagues, including Ekkehard Moessner and Ralf Hosse. Their joint efforts have fostered a collaborative environment, enhancing the development of transformative therapies in the realm of immunology.

Conclusion

In summary, Thomas U Hofer's contributions to the field of antibody therapeutics highlight his role as an inventor who actively drives innovation. His patents not only reflect his technical expertise but also promise to impact therapeutic strategies for treating diseases. As he continues his work in Zurich, the scientific community eagerly anticipates further advancements emerging from his innovative endeavors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…